Neumosaflid Tablet (Mosapride Citrate Hydrate)

Adult dose

Adults: Administer 15 mg of mosapride citrate anhydrous orally in 3 divided doses before or after meals.

This medication contains lactose, so it should not be used by patients with a genetic problem that prevents the digestion of lactose. While taking this medication, side effects such as diarrhea, dry mouth, and lethargy may occur, so caution is advised. Since it may cause liver dysfunction, if symptoms of hepatitis or jaundice appear, the medication should be stopped immediately and a doctor's consultation is needed. An allergic reaction may cause rashes, hives, or swelling, so caution is advised if any skin abnormalities occur. Gastrointestinal symptoms such as indigestion, vomiting, and abdominal pain may occur, so it is advisable to consult a doctor if discomfort persists. The effectiveness of this medication may be reduced when taken with anticholinergics; therefore, dosing timings should be adjusted when using both. Pregnant or breastfeeding women should use this medication with caution and consult a doctor if necessary. Safety has not been established for children, so it is advisable not to use it in this population. Elderly patients should be monitored closely as kidney and liver function may decline, and if adverse reactions occur, appropriate measures such as dose reduction should be taken. This medication should be stored out of reach of children, and transferring it to another container should be avoided.

• Diarrhea
• loose stools
• thirst
• fatigue
• eosinophilia
• increased triglycerides
• elevated AST
• elevated ALT
• elevated ALP
• elevated γ-GTP

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, avoid extremely hot or cold places, and it is best to store it at room temperature between 1°C and 30°C.

Appearance

This medication is a white film-coated tablet with a dividing line and a rectangular shape.

Package unit

30 tablets/bottle, 300 tablets/bottle